Join to view full profile
450 Brookline AveBoston, MA 02215
Phone+1 617-632-3270
Fax+1 617-632-4410
Dr. Horan is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Rochester Medical CenterFellowship, Pediatric Hematology/Oncology, 1998 - 2000
Children's National Hospital/George Washington UniversityFellowship, Pediatric Hematology/Oncology, 1997 - 1998
University of Rochester Medical CenterResidency, Pediatrics, 1993 - 1996
Rutgers New Jersey Medical SchoolClass of 1993
Certifications & Licensure
NY State Medical License 1996 - 2028
MA State Medical License 2012 - 2025
GA State Medical License 2004 - 2021
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
Publications & Presentations
PubMed
- Allogeneic HSCT outcomes and impact of defibrotide prophylaxis on SOS after inotuzumab in pediatric B-ALL.Jonathan D Paolino, Kyle Hebert, Jiemin Yang, Christine N Duncan, Steven P Margossian
Blood Advances. 2026-07-16 - 1 citationsRBC Alloimmunization Impacts Pediatric Sickle Cell Disease Transplant Outcomes and Transfusion Burden: A STAR Registry Report.Zaina Inam, Elizabeth Stenger, Tami D John, Katie Liu, Scott Gillespie
American Journal of Hematology. 2026-04-01 - Reconsidering an age-old question.John T Horan, Benjamin Watkins
Blood Advances. 2026-03-24
Journal Articles
- Treatment Strategies for Adolescent and Young Adult Patients with Acute Myeloid LeukemiaJohn T Horan, David R Freyer, Blood
Abstracts/Posters
- Pediatric Hematologist/OncologistsÍ Beliefs about Hematopoietic Stem Cell Transplant for Children with Sickle Cell Disease: A Sickle Cell Transplant Advocacy and Resea...John T. Horan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Transcriptomic Analysis of CD4+ T Cell Dysfunction during Gvhd: Evidence for Profound Reprograming of T Cell Signaling during Acute Gvhd That Is Controlled during CD28...John T. Horan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
UR Medicine Golisano Children’s Hospital to Lead Groundbreaking Sickle Cell Treatment StudyNovember 6th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:










